This inventor holds 1 USPTO granted patent. Top assignees: Synphar Laboratories, Inc., Taiho Pharmaceutical Company Limited. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2000
Title: Yadagiri Bathini: Innovator in Fungal Infection Treatment
Introduction
Yadagiri Bathini is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for fungal infections. His innovative work has led to the granting of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Yadagiri Bathini holds a patent for "Triazoles as therapeutic agents for fungal infections." This patent describes a compound of formula I, or an optical isomer or pharmaceutically acceptable salt thereof. The patent also includes a pharmaceutical composition and a method for treating or preventing fungal infections using the compound. This advancement represents a crucial step in the fight against fungal infections, providing new options for treatment.
Career Highlights
Throughout his career, Yadagiri Bathini has worked with reputable companies in the pharmaceutical industry. He has been associated with Synphar Laboratories, Inc. and Taiho Pharmaceutical Company Limited. His experience in these organizations has contributed to his knowledge and expertise in drug development and innovation.
Collaborations
Yadagiri has collaborated with several professionals in his field, including Mohsen Daneshtalab and Dai Q Nguyen. These collaborations have likely enriched his research and development efforts, leading to more effective solutions in the pharmaceutical sector.
Conclusion
Yadagiri Bathini's contributions to the field of pharmaceuticals, particularly through his patent for triazoles as therapeutic agents, highlight his role as an innovator in the treatment of fungal infections. His work continues to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile